Bintou Ahmadou Ahidjo

Ahmadou Ahidjo Bintou

Appointment(s)
  • Senior Research Fellow, Department of Microbiology & Immunology
Academic Qualifications
  • Johns Hopkins University, Center for Tuberculosis Research
Recent Publications
  • 1. Ahidjo, B. A., Maiga, M. C., Ihms, E. A., Maiga, M., Ordonez, A. A., Cheung, L. S., . . . Bishai, W. R. (2016). The antifibrotic drug pirfenidone promotes pulmonary cavitation and drug resistance in a mouse model of chronic tuberculosis.. JCI Insight, 1(14), e86017. doi:10.1172/jci.insight.86017.
  • 2. Ahidjo, B. A., & Bishai, W. R. (2016). Phosphodiesterase inhibitors as adjunctive therapies for tuberculosis. EBioMedicine, 4, 7-8. doi:10.1016/j.ebiom.2016.02.016.
  • 3. Maiga, M. C., Ahidjo, B. A., Maiga, M., & Bishai, W. R. (2015). Roflumilast, a Type 4 phosphodiesterase inhibitor, shows promising adjunctive, host-directed therapeutic activity in a mouse model of tuberculosis. Antimicrobial Agents and Chemotherapy, 59(12), 7888-7890. doi:10.1128/AAC.02145-15.
  • 4. Maiga, M., Ahidjo, B. A., Maiga, M. C., Cheung, L., Pelly, S., Lun, S., . . . Bishai, W. R. (2015). Efficacy of Adjunctive Tofacitinib Therapy in Mouse Models of Tuberculosis (vol 2, pg 868, 2015). EBIOMEDICINE, 2(11), 1834. doi:10.1016/j.ebiom.2015.10.019.
  • 5. Maiga, M., Ahidjo, B. A., Maiga, M. C., Cheung, L., Pelly, S., Lun, S., . . . Bishai, W. R. (2015). Efficacy of Adjunctive Tofacitinib Therapy in Mouse Models of Tuberculosis. EBioMedicine, 2(8), 868-873. doi:10.1016/j.ebiom.2015.07.014.